1. Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension. Issue 3 (11th September 2017) Authors: Spiekerkoetter, Edda; Sung, Yon K.; Sudheendra, Deepti; Scott, Valerie; Del Rosario, Patricia; Bill, Matthew; Haddad, Francois; Long-Boyle, Janel; Hedlin, Haley; Zamanian, Roham T. Journal: European respiratory journal Issue: Volume 50:Issue 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The time is now: model-based dosing to optimize drug therapy. (November 2017) Authors: Chan, Danna; Ivaturi, Vijay; Long-Boyle, Janel Journal: International journal of pharmacokinetics Issue: Volume 2:Number 4(2017) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THER-26. PHARMACOKINETIC AND UPDATED OUTCOME DATA FROM PNOC-002: A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS. (23rd April 2019) Authors: Nicolaides, Theodore; Margol, Ashley; Gajjar, Amar; Goldman, Stewart; Gauvain, Karen; Kilburn, Lindsay; Nazemi, Kellie; Minturn, Jane; Leary, Sarah; Whipple, Nicholas; Gururangan, Sridharan; Crawford, John; Long-Boyle, Janel; Wang, Hechuan; Ivaturi, Vijay; Aboian, Mariam; Molinaro, Annette; Muell... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗